Profile | GDS4284 / 226874_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3265.13 | 89 |
GSM687648 | Patient 402 control | 3221.12 | 89 |
GSM687653 | Patient 403 control | 3199.72 | 89 |
GSM687658 | Patient 404 control | 3355.9 | 90 |
GSM687663 | Patient 411 control | 2839.54 | 88 |
GSM687668 | Patient 422 control | 2830.86 | 88 |
GSM687673 | Patient 424 control | 3448.87 | 90 |
GSM687678 | Patient 425 control | 3340.84 | 90 |
GSM687683 | Patient 427 control | 3691.25 | 91 |
GSM687688 | Patient 428 control | 3483.64 | 90 |
GSM687695 | Patient 441 control | 4187.46 | 93 |
GSM687699 | Patient 443 control | 3476.89 | 90 |
GSM687704 | Patient 444 control | 3085.26 | 89 |
GSM687707 | Patient 448 control | 2861.76 | 88 |
GSM687712 | Patient 449 control | 3334.44 | 90 |
GSM687719 | Patient 450 control | 2947.21 | 89 |
GSM687724 | Patient 451 control | 3116.61 | 89 |
GSM687728 | Patient 452 control | 3973.91 | 91 |
GSM687646 | Patient 401 treated 24h | 3328.31 | 90 |
GSM687649 | Patient 402 treated 24h | 3419.85 | 90 |
GSM687665 | Patient 411 treated 24h | 3055.29 | 89 |
GSM687651 | Patient 402 treated 4 weeks | 3340.84 | 90 |
GSM687667 | Patient 411 treated 4 weeks | 2728.77 | 88 |
GSM687670 | Patient 422 treated 24h | 2938.75 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 2917.92 | 88 |
GSM687654 | Patient 403 treated 24h | 3403.65 | 90 |
GSM687675 | Patient 424 treated 24h | 2969.58 | 89 |
GSM687685 | Patient 427 treated 24h | 3946.31 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 2676.45 | 87 |
GSM687677 | Patient 424 treated 4 weeks | 3320.49 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 3247.78 | 89 |
GSM687692 | Patient 428 treated 4h | 3172.86 | 89 |
GSM687716 | Patient 449 treated 4h | 3152.23 | 89 |
GSM687722 | Patient 450 treated 4h | 3031.14 | 89 |
GSM687680 | Patient 425 treated 24h | 4477.74 | 92 |
GSM687690 | Patient 428 treated 24h | 3402.13 | 90 |
GSM687700 | Patient 443 treated 24h | 3954.73 | 92 |
GSM687705 | Patient 444 treated 24h | 4051.72 | 92 |
GSM687714 | Patient 449 treated 24h | 3271.87 | 89 |
GSM687721 | Patient 450 treated 24h | 2859.48 | 89 |
GSM687682 | Patient 425 treated 4 weeks | 5187.1 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 2781.72 | 88 |
GSM687702 | Patient 443 treated 4 weeks | 3012.73 | 89 |
GSM687718 | Patient 449 treated 4 weeks | 3441.53 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 3184.58 | 89 |
GSM687661 | Patient 404 treated 4h | 3242.18 | 89 |
GSM687710 | Patient 448 treated 4h | 2905.35 | 88 |
GSM687726 | Patient 451 treated 4h | 2937.36 | 89 |
GSM687730 | Patient 452 treated 4h | 3083.35 | 90 |
GSM687660 | Patient 404 treated 24h | 5512.43 | 94 |
GSM687697 | Patient 441 treated 24h | 6233.17 | 95 |
GSM687709 | Patient 448 treated 24h | 2582.35 | 87 |
GSM687725 | Patient 451 treated 24h | 3322.56 | 90 |
GSM687729 | Patient 452 treated 24h | 4389.43 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 4162.83 | 92 |
GSM687731 | Patient 452 treated 4 weeks | 3849.9 | 91 |